{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:47:08Z","timestamp":1759340828204},"reference-count":40,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":12296,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[1982]]},"DOI":"10.1002\/mpo.2950100713","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T15:17:27Z","timestamp":1171984647000},"page":"125-148","source":"Crossref","is-referenced-by-count":12,"title":["Drug control of Ara-C-resistant tumor cells"],"prefix":"10.1002","volume":"10","author":[{"given":"F. M.","family":"Schabel","sequence":"first","affiliation":[]},{"given":"H. E.","family":"Skipper","sequence":"additional","affiliation":[]},{"given":"M. W.","family":"Trader","sequence":"additional","affiliation":[]},{"given":"R. W.","family":"Brockman","sequence":"additional","affiliation":[]},{"given":"W. R.","family":"Laster","sequence":"additional","affiliation":[]},{"given":"T. H.","family":"Corbett","sequence":"additional","affiliation":[]},{"given":"D. P.","family":"Griswold","sequence":"additional","affiliation":[]}],"member":"311","reference":[{"key":"10.1002\/mpo.2950100713-BIB1","first-page":"425","volume":"61","author":"Barlogie","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1002\/mpo.2950100713-BIB2","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0014-2964(78)90002-6","volume":"14","author":"Barlogie","year":"1978","journal-title":"Eur J Cancer"},{"key":"10.1002\/mpo.2950100713-BIB3","first-page":"691","volume-title":"Pharmacological Basis of Cancer Chemotherapy (27th Annual Symposium on Fundamental Cancer Research, 1974, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston)","author":"Brockman","year":"1975","unstructured":": Circumvention of resistance. In: \u201cPharmacological Basis of Cancer Chemotherapy (27th Annual Symposium on Fundamental Cancer Research, 1974, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston).\u201d Baltimore: Williams and Wilkins Co., 1975, pp 691\u2013711."},{"key":"10.1002\/mpo.2950100713-BIB4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/978-3-642-65678-1_19","volume-title":"Antineoplastic and Immunosuppressive Agents I","author":"Brockman","year":"1974","unstructured":": Mechanisms of resistance. In (eds): \u201cAntineoplastic and Immunosuppressive Agents I.\u201d Berlin: Springer-Verlag, pp 352\u2013410, 1974."},{"key":"10.1002\/mpo.2950100713-BIB5","author":"Brockman","unstructured":": Unpublished data from Southern Research Institute."},{"key":"10.1002\/mpo.2950100713-BIB6","first-page":"3610","volume":"40","author":"Brockman","year":"1980","journal-title":"Cancer Res"},{"key":"10.1002\/mpo.2950100713-BIB7","author":"Chabner","year":"1981","unstructured":": Personal communication, 1981."},{"key":"10.1002\/mpo.2950100713-BIB8","first-page":"89","volume":"66","author":"Chabner","year":"1979","journal-title":"Bull Cancer (Paris)"},{"key":"10.1002\/mpo.2950100713-BIB9","author":"Corbett","unstructured":": Unpublished data from Southern Research Institute."},{"key":"10.1002\/mpo.2950100713-BIB10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/978-3-642-65806-8_13","volume-title":"Antineoplastic and Immunosuppressive Agents II","author":"Creasey","year":"1975","unstructured":": Arabinosylcytosine. In (eds): \u201cAntineoplastic and Immunosuppressive Agents II.\u201d Berlin: Springer-Verlag, pp 232\u2013256, 1975"},{"key":"10.1002\/mpo.2950100713-BIB11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jnci\/50.3.783","volume":"50","author":"DeWys","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/mpo.2950100713-BIB12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0014-2964(79)90081-1","volume":"15","author":"Ehmann","year":"1979","journal-title":"Eur J Cancer"},{"key":"10.1002\/mpo.2950100713-BIB13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-1-4831-9930-6.50011-3","volume-title":"Advances in Chemotherapy","volume":"2","author":"Frei","year":"1965","unstructured":": Progress and perspectives in the chemotherapy of acute leukemia. In , (eds): \u201cAdvances in Chemotherapy\u201d, Vol 2. New York: Academic Press, pp 269\u2013298, 1965."},{"key":"10.1002\/mpo.2950100713-BIB14","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/1097-0142(196905)23:5<1019::AID-CNCR2820230506>3.0.CO;2-N","volume":"23","author":"Gee","year":"1969","journal-title":"Cancer"},{"key":"10.1002\/mpo.2950100713-BIB15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-2952(72)90319-X","volume":"21","author":"Gray","year":"1972","journal-title":"Biochem Pharmacol"},{"key":"10.1002\/mpo.2950100713-BIB16","first-page":"1640","volume":"37","author":"Ho","year":"1977","journal-title":"Cancer Res"},{"key":"10.1002\/mpo.2950100713-BIB17","first-page":"235","volume-title":"Advances in Cancer Research","volume":"7","author":"Hutchison","year":"1963","unstructured":": Cross resistance and collateral sensitivity studies in cancer chemotherapy. In (eds): \u201cAdvances in Cancer Research\u201d, Vol. 7. New York: Academic Press, pp 235\u2013350, 1963."},{"key":"10.1002\/mpo.2950100713-BIB18","first-page":"95","volume":"20","author":"Laster","year":"1979","journal-title":"Proc Am Assoc Cancer Res Am Soc Clin Oncol"},{"key":"10.1002\/mpo.2950100713-BIB19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.1954.tb40015.x","volume":"60","author":"Law","year":"1954","journal-title":"Ann NY Acad Sci"},{"key":"10.1002\/mpo.2950100713-BIB20","first-page":"1481","volume":"36","author":"LePage","year":"1976","journal-title":"Cancer Res"},{"key":"10.1002\/mpo.2950100713-BIB21","first-page":"1390","volume":"39","author":"Rustum","year":"1979","journal-title":"Cancer Res"},{"key":"10.1002\/mpo.2950100713-BIB22","first-page":"379","volume-title":"The Proliferation and Spread of Neoplastic Cells (21st Annual Symposium on Fundamental Cancer Research, 1967, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston)","author":"Schabel","year":"1968","unstructured":": In vivo leukemic cell kill kinetics and \u201ccurability\u201d in experimental systems. In: \u201cThe Proliferation and Spread of Neoplastic Cells (21st Annual Symposium on Fundamental Cancer Research, 1967, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston).\u201d Baltimore: Williams and Wilkins Co., pp 379\u2013408, 1968."},{"key":"10.1002\/mpo.2950100713-BIB23","first-page":"595","volume-title":"Pharmacological Basis of Cancer Chemotherapy (27th Annual Symposium on Fundamental Cancer Research, 1974, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston)","author":"Schabel","year":"1975","unstructured":": Synergism and antagonism among antitumor agents. In: \u201cPharmacological Basis of Cancer Chemotherapy (27th Annual Symposium on Fundamental Cancer Research, 1974, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston).\u201d Baltimore: Williams and Wilkins Co., pp 595\u2013621, 1975."},{"key":"10.1002\/mpo.2950100713-BIB24","first-page":"665","volume":"60","author":"Schabel","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1002\/mpo.2950100713-BIB25","series-title":"NATO Advanced","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4615-9137-5_12","volume-title":"Nucleoside Analogues: Chemistry, Biology, and Medical Applications","volume":"26","author":"Schabel","year":"1979","unstructured":": Test systems for evaluating the antitumor activity of nucleoside analogues. In , (eds): \u201cNucleoside Analogues: Chemistry, Biology, and Medical Applications. Vol. 26. NATO Advanced Study Institutes Series A: Life Sciences\u201d. New York: Plenum Publishing Corp., pp 363\u2013394, 1979."},{"key":"10.1002\/mpo.2950100713-BIB26","author":"Schabel","unstructured":": Unpublished data from Southern Research Institute."},{"key":"10.1002\/mpo.2950100713-BIB27","first-page":"411","volume":"1","author":"Schabel","year":"1977","journal-title":"Pharmacol Ther A"},{"key":"10.1002\/mpo.2950100713-BIB28","first-page":"9","volume-title":"Nitrosoureas\u2014Current Status and New Developments","author":"Schabel","year":"1981","unstructured":", , , : Combination chemotherapy with nitrosoureas plus other anticancer drugs against animal tumors. In , , , , lpar;eds) \u201cNitrosoureas\u2014Current Status and New Developments.\u201d New York: Academic Press, pp 9\u201326, 1981."},{"key":"10.1002\/mpo.2950100713-BIB29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000401477","volume-title":"Antibiotics and Chemotherapy, Vol. 23, Fundamentals in Cancer Chemotherapy","author":"Schabel","year":"1978","unstructured":": Some variables in experimental tumor systems which complicate interpretation of data from in vivo kinetic and pharmacologic studies with anticancer drugs. In (ed): \u201cAntibiotics and Chemotherapy, Vol. 23, Fundamentals in Cancer Chemotherapy.\u201d Basel: S. Karger, pp 113\u2013127, 1978."},{"key":"10.1002\/mpo.2950100713-BIB30","first-page":"199","volume-title":"Breast Cancer. Experimental and Clinical Aspects","author":"Schabel","year":"1980","unstructured":", , , , : Concepts for controlling drug-resistant tumor cells. In (eds): \u201cBreast Cancer. Experimental and Clinical Aspects.\u201d Oxford: Pergamon Press, pp 199\u2013211, 1980."},{"key":"10.1002\/mpo.2950100713-BIB31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000401484","volume-title":"Antibiotics and Chemotherapy, Vol. 23, Fundamentals in Cancer Chemotherapy","author":"Schabel","year":"1978","unstructured":", , , : Patterns of resistance and therapeutic synergism among alkylating agents. In: (ed): \u201cAntibiotics and Chemotherapy, Vol. 23, Fundamentals in Cancer Chemotherapy.\u201d Basel: S. Karger, pp 200\u2013215, 1978."},{"key":"10.1002\/mpo.2950100713-BIB32","first-page":"23","volume":"60","author":"Schmid","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1002\/mpo.2950100713-BIB33","first-page":"143","volume":"54","author":"Simpson-Herren","year":"1970","journal-title":"Cancer Chemother Rep Part 1"},{"key":"10.1002\/mpo.2950100713-BIB34","volume-title":"Cancer Chemotherapy\u2014Volume 1: Reasons for Success and Failure in Treatment of Murine Leukemias with the Drugs Now Employed in Treating Human Leukemias","author":"Skipper","year":"1978","unstructured":": \u201cCancer Chemotherapy\u2014Volume 1: Reasons for Success and Failure in Treatment of Murine Leukemias with the Drugs Now Employed in Treating Human Leukemias\u201d Ann Arbor, Michigan: University Microfilms International, 1978."},{"key":"10.1002\/mpo.2950100713-BIB35","volume-title":"Cancer Chemotherapy\u2014Volume 3: Idealized Hypothetical Illustrations of the Effects of Specifically Drug-Resistant Leukemia Cells on End-Results Achievable with Single Drugs and Combinations","author":"Skipper","year":"1979","unstructured":": \u201cCancer Chemotherapy\u2014Volume 3: Idealized Hypothetical Illustrations of the Effects of Specifically Drug-Resistant Leukemia Cells on End-Results Achievable with Single Drugs and Combinations.\u201d Ann Arbor, Michigan: University Microfilms International, 1979."},{"key":"10.1002\/mpo.2950100713-BIB36","first-page":"431","volume":"54","author":"Skipper","year":"1970","journal-title":"Cancer Chemother Rep Part 1"},{"key":"10.1002\/mpo.2950100713-BIB37","first-page":"1","volume":"35","author":"Skipper","year":"1964","journal-title":"Cancer Chemother Rep"},{"key":"10.1002\/mpo.2950100713-BIB38","first-page":"125","volume":"51","author":"Skipper","year":"1967","journal-title":"Cancer Chemother Rep"},{"key":"10.1002\/mpo.2950100713-BIB39","first-page":"685","volume":"48","author":"Wilkoff","year":"1972","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/mpo.2950100713-BIB40","first-page":"521","volume":"65","author":"Yap","year":"1981","journal-title":"Cancer Treat Rep"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.2950100713","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/mpo.2950100713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T15:40:48Z","timestamp":1625413248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.2950100713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982]]},"references-count":40,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1982]]}},"URL":"https:\/\/doi.org\/10.1002\/mpo.2950100713","relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982]]}}}